DXCM DexCom, Inc.

NASDAQ
$86.62

DexCom, Inc. (DXCM) is expected to report earnings on October 28, 2026, after the market close. The consensus earnings estimate is $0.66 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +8.4% since its last earnings release on July 30, 2026.

DexCom Beat Expectations, Narrows Guidance
Thursday, July 30, 2026 · 4:02 PM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 28
Wednesday · 4:00 PM ET
Earnings Whisper
-
vs $0.66
Rev est $1.32B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $87.77

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About DexCom, Inc.

DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 14 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.